Live Breaking News & Updates on Jeffrey lakritz

Stay informed with the latest breaking news from Jeffrey lakritz on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Jeffrey lakritz and stay connected to the pulse of your community

Dangers in giving magnesium sulfate intravenously to horses highlighted in study

Horsetalk.co.nz
Dangers in giving magnesium sulfate intravenously to horses highlighted in study
Intravenous administration of magnesium sulfate to horses to provide a competitive edge is a nefarious and dangerous practice, say researchers.
Magnesium is an essential macroelement involved in many physiological processes.
In equine medicine, intravenous magnesium sulfate is used to treat heart rhythm irregularities, neurological disorders, low magnesium levels in the blood that might arise during critical illness, and for low levels of calcium in the blood which are not responding to other treatments.
However, more recently, intravenous magnesium has been used in equine events as a calming and performance-enhancing agent, with the ultimate goal of giving a competitive edge to horses that receive it. It is a practice forbidden at FEI events under the international governing body’s anti-doping rules because of its calming and metabolic effects.

Stephen-schumacher , Jeffrey-lakritz , Ramiro-toribio , Teresa-burns , Ahmed-kamr , Alicia-bertone , Researchers-at-ohio-state-university , Ohio-state-university , Creative-commons-license , ஸ்டீபன்-ஷூமேக்கர் , ஜெஃப்ரி-லக்ரிட்ஸ் , ரெமிரொ-டோரிபியோ

Nanobodies may be the key to blocking tick-borne bacterial infection

Nanobodies may be the key to blocking tick-borne bacterial infection
Tiny molecules called nanobodies, which can be designed to mimic antibody structures and functions, may be the key to blocking a tick-borne bacterial infection that remains out of reach of almost all antibiotics, new research suggests.
The infection is called human monocytic ehrlichiosis, and is one of the most prevalent and potentially life-threatening tick-borne diseases in the United States. The disease initially causes flu-like symptoms common to many illnesses, and in rare cases can be fatal if left untreated.
Most antibiotics can't build up in high enough concentrations to kill the infection-causing bacteria, Ehrlichia chaffeensis, because the microbes live in and multiply inside human immune cells. Commonly known bacterial pathogens like Streptococcus and E. coli do their infectious damage outside of hosts' cells.

Ohio , United-states , Ohio-state-university , Dehua-pei , Jeffrey-lakritz , Yasuko-rikihisa , Emily-henderson , Proceedings-of-the-national-academy-sciences , State-university , National-academy , Ohio-state , Nanobodies

Using nanobodies to block a tick-borne bacterial infection

Using nanobodies to block a tick-borne bacterial infection
Tiny molecules called nanobodies, which can be designed to mimic antibody structures and functions, may be the key to blocking a tick-borne bacterial infection that remains out of reach of almost all antibiotics, new research suggests.
The infection is called human monocytic ehrlichiosis, and is one of the most prevalent and potentially life-threatening tick-borne diseases in the United States. The disease initially causes flu-like symptoms common to many illnesses, and in rare cases can be fatal if left untreated.
Most antibiotics can’t build up in high enough concentrations to kill the infection-causing bacteria,

Ohio , United-states , Ohio-state-university , Mingqun-lin , Hongyan-liu , Khemraj-budachetri , Ashweta-sahni , Dehua-pei , Jeffrey-lakritz , Libo-hou , Qi-yan , Yasuko-rikihisa

Study uses nanobodies to block tick-borne bacterial infection

Study uses nanobodies to block tick-borne bacterial infection
ANI |
Updated: Apr 28, 2021 23:28 IST
Washington [US], April 28 (ANI): The findings of recent research suggest that tiny molecules called nanobodies, which can be designed to mimic antibody structures and functions, might be the key to blocking a tick-borne bacterial infection that remains out of reach of almost all antibiotics.
The research is published this week in Proceedings of the National Academy of Sciences. The infection is called human monocytic ehrlichiosis and is one of the most prevalent and potentially life-threatening tick-borne diseases in the United States. The disease initially causes flu-like symptoms common to many illnesses, and in rare cases can be fatal if left untreated.

Ohio , United-states , Washington , Ohio-state-university , Dehua-pei , Jeffrey-lakritz , Yasuko-rikihisa , Proceedings-of-the-national-academy-sciences , National-academy , State-university , Ohio-state , ஓஹியோ

Using nanobodies to block a tick-borne bacterial infection

Using nanobodies to block a tick-borne bacterial infection
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

Columbus , Ohio , United-states , Ohio-state-university , Mingqun-lin , Hongyan-liu , Khemraj-budachetri , Ashweta-sahni , Dehua-pei , Jeffrey-lakritz , Libo-hou , Emily-caldwell